The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ATLANTIS: Global, randomized phase III study of lurbinectedin (L) with doxorubicin (DOX) vs. CAV or topotecan (T) in small-cell lung cancer after platinum therapy.
 
Anna F. Farago
Honoraria - Foundation Medicine
Consulting or Advisory Role - Abbvie; Intervention Insights; Loxo; Merrimack; PharmaMar; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Loxo (Inst); Merck (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie/Stemcentrx; PharmaMar
 
Luis G. Paz-Ares
No Relationships to Disclose
 
Tudor-Eliade Ciuleanu
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - A&D Pharma; Amgen; AstraZeneca; Boehringer Ingelheim; Ipsen; Merck; Pfizer; Sanofi; Servier
 
Andrea Fülop
No Relationships to Disclose
 
Alejandro Navarro
No Relationships to Disclose
 
Laura Bonanno
No Relationships to Disclose
 
Jose Antonio Lopez-Vilariño
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Rafael Nuñez
Employment - PharmaMar
 
Carmen Maria Kahatt
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Gabor Kos
No Relationships to Disclose
 
Arturo Soto-Matos
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar